Absorb GT1 Bioresorbable Vascular Scaffold (BVS) by Abbott Vascular: UPDATED Letter to Health Care Providers - FDA Investigating Increased Rate of Major Adverse Cardiac Events
If your email program has trouble displaying this email, view it as a web page |
| ||||
U.S. Food and Drug Administration |
Comments
Post a Comment